Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
Assessment of Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
1 other identifier
observational
50
1 country
1
Brief Summary
This study aims to evaluate the progression of non-center-involving diabetic macular edema in the early postoperative period following phacoemulsification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
June 26, 2025
CompletedStudy Start
First participant enrolled
June 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJuly 1, 2025
June 1, 2025
5 months
June 18, 2025
June 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Best Corrected Visual Acuity
Best Corrected Visual Acuity (BCVA) will be recorded.
6 months post-procedure
Secondary Outcomes (3)
Intra ocular pressure
6 months post-procedure
Central macular thickness (CMT)
6 months post-procedure
Frequency distribution of Fluorescein leakage
6 months post-procedure
Study Arms (1)
Study group
Patients with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME)
Interventions
Coloured photography will be performed preoperatively and at 3 and 6 months postoperatively.
Fluorescein angiography will be performed preoperatively and at 3 and 6 months postoperatively. The following features will be recorded on each angiography:
Optical coherence tomography (OCT) scanning will be performed using the optical coherence tomography scanner OCT (OPTOVUE OCT). OCT will be performed preoperatively and at 3 and 6 months postoperatively.
Eligibility Criteria
This prospective study will be conducted on 50 diabetic patients aged ≥18 years, both sexes, with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME).
You may qualify if:
- Age ≥18 years.
- Both sexes.
- Patients with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME).
You may not qualify if:
- Traumatic cataract.
- Severe Non-Proliferative/ Proliferative Diabetic Retinopathy.
- Marked Asymmetry of retinopathy between both eyes.
- Mature senile cataract or severe lens opacity.
- Potentiality to have Phacotrabeculectomy surgery.
- Complications during or after the surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, 11591, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Study Record Dates
First Submitted
June 18, 2025
First Posted
June 26, 2025
Study Start
June 29, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.